This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Tsujimoto, H. Articles by Mochizuki, H. Search for Related Content PubMed PubMed Citation Articles by Tsujimoto, H. Articles by Mochizuki, H. Social Bookmarking                         What's this?

Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+CD14 + monocytes in patients with septic shock

Department of Surgery I, National Defense Medical College Research Institute, Saitama, Japan

Satoshi Ono

Department of Surgery I, National Defense Medical College Research Institute, Saitama, Japan, satoshi{at}me.ndmc.ac.jp

Shuichi Hiraki

Department of Surgery I, National Defense Medical College Research Institute, Saitama, Japan

Takashi Majima

Department of Surgery I, National Defense Medical College Research Institute, Saitama, Japan

Nobuaki Kawarabayashi

Department of Surgery I, National Defense Medical College Research Institute, Saitama, Japan

Hidekazu Sugasawa

Department of Surgery I, National Defense Medical College Research Institute, Saitama, Japan

Manabu Kinoshita

Division of Basic Traumatology, National Defense Medical College Research Institute, Saitama, Japan

Hoshio Hiraide

Division of Basic Traumatology, National Defense Medical College Research Institute, Saitama, Japan

Hidetaka Mochizuki

Department of Surgery I, National Defense Medical College Research Institute, Saitama, Japan

Background: CD16 ⁺CD14⁺ monocytes dramatically increase in number in patients with severe infection. Hemoperfusion with PMX-F (direct hemoperfusion with polymyxin B immobilized fibers) has been reported to be a safe and effective treatment for patients with septic shock, although the molecular mechanism that accounts for its effectiveness is still unclear. The purpose of this study was to quantify the number of CD16⁺CD14⁺ monocytes in patients with an intra-abdominal infection and to evaluate the effects of PMX-F treatment on clinical parameters and leukocyte surface antigen expression in these patients.

Materials and Methods : Seventeen septic patients who had an intra-abdominal infection were enrolled in this study; 7 of these patients received PMX-F treatment. Peripheral blood samples were obtained immediately after admission, and were also collected from the above 7 patients before, during, and immediately after their PMX-F treatment. The expression of CD14, CD16, and Toll-like receptor (TLR)-4 on these patients' monocytes was evaluated using flow cytometry. In addition, lipopolysaccharide (LPS)-induced production of TNF- and IL-1ß by these cells was measured by ELISA.

Results: Monocytic expression of CD16 and TLR-4 was significantly greater in septic patients than in healthy controls, and their proportion of CD16⁺CD14 ⁺ monocytes was similarly elevated. LPSinduced production of TNF- and IL-1ß by peripheral blood mononuclear cells (PBMCs) of septic patients was significantly reduced compared to controls. Furthermore, there was a reduction in the proportion of CD 16⁺CD 14⁺ monocytes during PMX-F treatment, and in the expression of TLR-4 on monocytes after PMX-F treatment.

Conclusions: These results showed that the number of peripheral blood CD16⁺CD14 ⁺ monocytes and monocytic TLR-4 expression were markedly increased, and the production of pro-inflammatory cytokines in response to LPS significantly reduced in patients with sepsis. PMX-F treatment was found to be effective in reducing the number of CD 16⁺CD 14⁺ monocytes and in decreasing the monocytic expression of TLR-4 in patients with septic shock.

Key Words: Polymyxin B-immobilized fiber (PMX) • sepsis • CD16+CD14+ monocytes

Journal of Endotoxin Research, Vol. 10, No. 4, 229-237 (2004)
DOI: 10.1177/09680519040100040501


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. N. Cruz, M. Antonelli, R. Fumagalli, F. Foltran, N. Brienza, A. Donati, V. Malcangi, F. Petrini, G. Volta, F. M. Bobbio Pallavicini, et al. Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock: The EUPHAS Randomized Controlled Trial JAMA, June 17, 2009; 301(23): 2445 - 2452. [Abstract] [Full Text] [PDF]